Advance Oncotherapy - Interview with Gabriel Urwitz | Broadcast | BRR Media

Advance Oncotherapy - Interview with Gabriel Urwitz

AVO Thu, 03 Aug 2017, 09:00am BST

Gabriel Urwitz, Executive Chairman of AB Segulah, the nordic private equity firm, speaks about the loan provided to Advanced Oncotherapy, the rationale behind the decision and his view on the technology.

AVO Team

AVO Team

Company Events - ADVANCED ONCOTHERAPY

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Advanced Oncotherapy - Distribution agreement and Equity...

Nicolas Serandour, CEO

Mon, 11 Dec 2017, 7:00am GMT

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

AVO - Progress at Harley Street, timelapse

AVO Team, AVO Team

Mon, 23 Oct 2017, 7:00am BST

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Advanced Oncotherapy - Technological update

Nicolas Serandour, CEO

Tue, 5 Sep 2017, 9:05am BST

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Advance Oncotherapy - Interview with Gabriel Urwitz...

AVO Team, AVO Team

Thu, 3 Aug 2017, 9:00am BST

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Advanced Oncotherapy - Harley Street update with Deconstruct...

Mick Durie, Director, Deconstruct

Wed, 5 Jul 2017, 6:30am BST